Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-37133230
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Future Oncol
Year:
2023
Type:
Article
Affiliation country:
Turkey